Cambrex Completes Acquisition of Avista Pharma Solutions

East Rutherford, NJ – January 2, 2019Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms, today announced that it has completed the acquisition of Avista Pharma Solutions (“Avista”), a contract development, manufacturing, and testing organization, from Ampersand Capital Partners. The transaction, announced on November 20, 2018, strengthens Cambrex’s position as the leading, fully integrated small molecule contract development and manufacturing organization (CDMO) across […]

Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network

East Rutherford, NJ – November 20, 2018 – Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms, today announced it has entered into a definitive agreement to acquire Avista Pharma Solutions (Avista), a contract development, manufacturing, and testing organization, for approximately $252 million.  Avista is a portfolio company of Ampersand Capital Partners, a leading healthcare focused private equity firm.  With this acquisition, Cambrex will enter the large […]

By |November 20th, 2018|Company, News|0 Comments

Free One Day Seminar in Cambridge, MA, USA

Solid Form Solutions are pleased to announce that they will be hosting a free one day seminar at the Marlowe Hotel, Cambridge, MA, on 12th September 2014. The event will focus on solid state research and its importance and application to the pharmaceutical industry. From unique bench scale solid form screening studies to particle design and control in large scale crystallisation campaigns, members of the SFS technical team will cover a vast selection of topics and provide insight into the latest advances in these […]

We Are Recruiting!

Due to further expansion, Solid Form Solutions are recruiting for solid form screening scientists. Further details are available on request or at:

SFS Growth Continues With The Purchase of an Additional XRPD

Solid Form Solutions Ltd have increased their XRPD capabilities with the purchase of an additional state-of the-art X-ray Powder Diffractometer. The XYZ stage capability of the new instrument as well as quick transmission/reflection change-around,  provides SFS with unrivalled capabilities in data quality, speed and future development of their screens. SFS CEO Dr Stephen Watt says “These are exciting times for SFS and our services. Our new instrument has propelled SFS to unmatched heights in terms of data quality and […]

Dr Craig Grant Joins SFS

Solid Form Solutions Ltd today announced the appointment of Dr Craig Grant to the project management team at SFS. Dr Grant brings over 20 years experience in solid-state science to SFS having held leading positions at Millennium Pharmaceuticals, Exova and other solid-state CROs. Solid Form Solutions CEO Dr Stephen Watt says “It is great to be teaming up with Craig again. This is a great appointment for SFS and will add strength and depth to our already well equipped […]

By |October 29th, 2013|News, Staff|0 Comments

Meet with SFS at ChemOutsourcing, Stand 20

Solid Form Solutions will be exhibiting at this year’s ChemOutsourcing (17th-19th September), Stand 20. Come along to Stand 20 and hear about our latest advances in Solid Solid Screening and Scale-up crystallization.  Hear about innovative Particle Engineering programs and how all of our services have helped reduce risk and cost in drug development. We will be talking about our recent MHRA audit of SFS Analytical and subsequent certification along with our plans for the future.


MHRA Approves Solid Form Solutions

After a recent inspection from the MHRA of the SFS Analytical Service, SFS operations have now been confirmed to be in general compliance with the principles and guidelines of good manufacturing practice as laid out in Commission Directive 2003/94/EC. The inspection, held over two days, and covering both the quality management system and the analytical laboratory operations, resulted in a successful conclusion with no critical or major findings noted. The standalone SFS Analytical Service will now be formally launched […]

SFS and Tillotts Pharma AG

SFS a world leading contract research organization (CRO) providing the pharmaceutical industry with “solid state“ chemical development services while Tillotts Services (a business unit within Tillotts) is a leading global supplier of liquid-filled capsules and operates a drug delivery and integrated cro/cmo service. The business activities and services provided by both companies are complementary and will be able to offer Customers an integrated service from API development and characterisation all the way through to formulation design, clinical and commercial […]

Focused Beam Reflectance Measurement (FBRM)

Solid Form Solutions has strengthened their batch process development service by making a large investment in Focused Beam Reflectance Measurement (FBRM) Technology. FBRM has a particular application in crystallisation work, where it is a valuable tool for monitoring particle size and crystal growth, in-situ; leading to more more efficient crystallisation and isolation processes. To learn more about SFS’s capability in this area, contact us…

Send a message
Leave a message and we'll get back to you, asap.
Your name
* Email
* Describe your issue
Login Chat
Questions? We're online: send us a message!
Your name
* Email
We're online!